Olympus Launches New Peracetic Acid Solution for High-Level Disinfection

Olympus has announced the release of Acecide-C, a new, peracetic acid-based high-level disinfectant and sterilant, according to a news release from Olympus.

Advertisement

 

Acecide-C High-Level Disinfectant and Sterilant is an aldehyde-free, liquid chemical germicide designed for use in the Olympus Endoscope Reprocessor, the OER-Pro.

 

The peracetic acid solution was co-developed by Olympus and Saraya Co. (manufactured by Best Sanitizers).

“Superior infection control solutions are of the utmost importance in the healthcare industry,” said Rick Harbuck, group vice president, endoscopy division for Olympus America, in the release. “The introduction of Acecide-C provides our OER-Pro customers with another fast and effective option to meet their reprocessing needs while protecting their valuable equipment. We are pleased to collaborate with Saraya Co., Ltd., a recognized leader in the sanitation and healthcare industry, to enhance solutions for our customers, ultimately leading to better patient care.”

 

More Articles Featuring Olympus:

5 Steps to Ensure Quality at GI-Driven ASCs

ASC Equipment Tip: Be Smart About Reprocessed Equipment Purchase

Olympus America, Caris Diagnostics Partner on New Pathology Reporting Tool

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in GI & Endoscopy

  • Birmingham (Ala.) Gastroenterology has opened a clinic in Jasper, Ala., expanding access to digestive health services in the region, the…

  • Premier Health Partners has acquired Dayton, Ohio-based Digestive Specialists, according to a notice posted on the website of law firm…

Advertisement

Comments are closed.